Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03070340 · ClinicalTrials.gov registry record · NA
Comparison of MRI and CEDM to Evaluate Treatment Response Before Surgery
A NA study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 125
- Enrollment target
NCT03070340: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03070340 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 125 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03070340, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the diagnostic accuracy of breast magnetic resonance imaging (MRI) and contrast enhanced digital mammography (CEDM) in assessing the residual disease extent in patients who have completed neoadjuvant therapy (NAT).
Interventions
- DIAGNOSTIC_TEST Breast Magnetic Resonance Imaging (MRI)
- DIAGNOSTIC_TEST Contrast Enhanced Mammography (CEDM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2017-02-28 |
| Est. Completion | 2023-11-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03070340
The ClinicalTrials.gov registry entry for NCT03070340 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Breast Magnetic Resonance Imaging (MRI) is the first listed.
NCT03070340 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03070340 about?
NCT03070340 is a clinical study titled "Comparison of MRI and CEDM to Evaluate Treatment Response Before Surgery". The purpose of this study is to compare the diagnostic accuracy of breast magnetic resonance imaging (MRI) and contrast enhanced digital mammography (CEDM) in assessing the residual disease extent in patients who have completed neoadjuvant therapy (NAT).
What is the current status of trial NCT03070340?
This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2017-02-28. Estimated completion is 2023-11-17.
What interventions are being tested in trial NCT03070340?
The interventions under investigation include: Breast Magnetic Resonance Imaging (MRI) (DIAGNOSTIC_TEST), Contrast Enhanced Mammography (CEDM) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03070340?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.